| pubmed-article:21253305 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21253305 | lifeskim:mentions | umls-concept:C0006826 | lld:lifeskim |
| pubmed-article:21253305 | lifeskim:mentions | umls-concept:C0229671 | lld:lifeskim |
| pubmed-article:21253305 | lifeskim:mentions | umls-concept:C0005516 | lld:lifeskim |
| pubmed-article:21253305 | lifeskim:mentions | umls-concept:C1954261 | lld:lifeskim |
| pubmed-article:21253305 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:21253305 | pubmed:dateCreated | 2011-1-21 | lld:pubmed |
| pubmed-article:21253305 | pubmed:abstractText | Serum YKL-40 has been linked to several human cancers. We investigated the potential role of serum YKL-40 as a marker of hepatobiliary malignancies. | lld:pubmed |
| pubmed-article:21253305 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21253305 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21253305 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21253305 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21253305 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21253305 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21253305 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21253305 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21253305 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21253305 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21253305 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21253305 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21253305 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21253305 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21253305 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21253305 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21253305 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21253305 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21253305 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21253305 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21253305 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21253305 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21253305 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21253305 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21253305 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21253305 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21253305 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21253305 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21253305 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21253305 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21253305 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21253305 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21253305 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21253305 | pubmed:status | PubMed-not-MEDLINE | lld:pubmed |
| pubmed-article:21253305 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:21253305 | pubmed:issn | 1976-2283 | lld:pubmed |
| pubmed-article:21253305 | pubmed:author | pubmed-author:KimEugeneE | lld:pubmed |
| pubmed-article:21253305 | pubmed:author | pubmed-author:KimW RayWR | lld:pubmed |
| pubmed-article:21253305 | pubmed:author | pubmed-author:PungpapongSur... | lld:pubmed |
| pubmed-article:21253305 | pubmed:author | pubmed-author:RobertsLewis... | lld:pubmed |
| pubmed-article:21253305 | pubmed:author | pubmed-author:PedersenRache... | lld:pubmed |
| pubmed-article:21253305 | pubmed:author | pubmed-author:YangJu DongJD | lld:pubmed |
| pubmed-article:21253305 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:21253305 | pubmed:volume | 4 | lld:pubmed |
| pubmed-article:21253305 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21253305 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21253305 | pubmed:pagination | 537-42 | lld:pubmed |
| pubmed-article:21253305 | pubmed:dateRevised | 2011-7-20 | lld:pubmed |
| pubmed-article:21253305 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:21253305 | pubmed:articleTitle | Utility of Serum YKL-40 as a Tumor-Specific Marker of Hepatobiliary Malignancies. | lld:pubmed |
| pubmed-article:21253305 | pubmed:affiliation | Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN, USA. | lld:pubmed |
| pubmed-article:21253305 | pubmed:publicationType | Journal Article | lld:pubmed |
